Lecturer, Jefferson College of Population Health

Subjective Outcomes In Health Evaluation 

Douglas McKell is the former Senior Vice President and Chief Administrative Officer/Chief Executive Officer of several large single (surgery) and multispeciality proup practices in New England. Under his leadership he merged a number of practices, grew market share, expanded geographic coverage, and increased outpatient service access, in addition to successfully managing a Medicare full-risk capitation contract for 4 years. Previous to these positions,he was a senior partner in a physician management consulting firm with a national client base for 10 years. 

Douglas McKell is an experienced healthcare professional with proven ability achieving operational excellence and implementing multiple successful business strategies supporting a new career in graduate health professions teaching with specific focus on: Organizatonal Quality Improvement; Patient Safety & Medical Error Prevention; High Value clinical outcomes for chronic diseases; Applied Behavioral Economics, Diagnostic and Medical Decision-Making; Learned Professionalism (EPAs); Analytic Pharmacoeconomics; and IOM's emphasis on Right Care, Right Patient, Right Outcomes, Right Resources, and Right Time.

He is a dedicated instructor with broad understanding of the complex healthcare environment coupled with training in health professions education with a focus on quality measurement, medical decision-making, clinical information transfer, operational effectiveness and financial efficiency, value-based contracting for improved patient care with careful analysis of resource utilization, team-based care and better long-term outcomes. He also has a specific interest in improving leadership behavior through the understanding and management of cognitive biases, including social cognition and learning process of health care providers.

His experience includes applied behavioral health economics and outcomes research, including over 10 years actively working at the national level to improve appropriate pharmaceutical use, specifically high-cost products for chronic disease treatment, in order to achieve lower cost and higher value patient outcomes. He is an ongoing national consultant for improved clinical outcomes to the National Hemophilia Foundation, the Crohn’s & Colitis Foundation, the Multiple Sclerosis Association of America, and Diabetes. Additionally, he has moderated the Continuing Care Sustainability Collaborative for Hemophilia (payer-provider national policy) for 5 years, the Value-Based Care Collaborative for Rare Diseases for 1 year, and two national Gene Therapy Symposiums for two years.